These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27374048)

  • 21. Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.
    Bozkurt B; Fonarow GC; Goldberg LR; Guglin M; Josephson RA; Forman DE; Lin G; Lindenfeld J; O'Connor C; Panjrath G; Piña IL; Shah T; Sinha SS; Wolfel E;
    J Am Coll Cardiol; 2021 Mar; 77(11):1454-1469. PubMed ID: 33736829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise Training in Group 2 Pulmonary Hypertension: Which Intensity and What Modality.
    Arena R; Lavie CJ; Borghi-Silva A; Daugherty J; Bond S; Phillips SA; Guazzi M
    Prog Cardiovasc Dis; 2016; 59(1):87-94. PubMed ID: 26569571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reasonable expectations: how much aerobic capacity, muscle strength, and quality of life can improve with exercise training in heart failure.
    Williams MA; Pozehl B
    Heart Fail Clin; 2015 Jan; 11(1):37-57. PubMed ID: 25432473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home-based telemonitored Nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices: a randomised controlled study.
    Piotrowicz E; Zieliński T; Bodalski R; Rywik T; Dobraszkiewicz-Wasilewska B; Sobieszczańska-Małek M; Stepnowska M; Przybylski A; Browarek A; Szumowski Ł; Piotrowski W; Piotrowicz R
    Eur J Prev Cardiol; 2015 Nov; 22(11):1368-77. PubMed ID: 25261268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction.
    Zile MR; Bourge RC; Redfield MM; Zhou D; Baicu CF; Little WC
    JACC Heart Fail; 2014 Apr; 2(2):123-30. PubMed ID: 24720918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular ejection fraction as therapeutic target: is it the ideal marker?
    Katsi V; Georgiopoulos G; Laina A; Koutli E; Parissis J; Tsioufis C; Nihoyannopoulos P; Tousoulis D
    Heart Fail Rev; 2017 Nov; 22(6):641-655. PubMed ID: 28601914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MY APPROACH to heart failure with preserved ejection fraction.
    Borlaug BA
    Trends Cardiovasc Med; 2014 Nov; 24(8):369-70. PubMed ID: 25267507
    [No Abstract]   [Full Text] [Related]  

  • 29. Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.
    Borlaug BA; Koepp KE; Melenovsky V
    J Am Coll Cardiol; 2015 Oct; 66(15):1672-82. PubMed ID: 26449137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerobic Interval Training Elicits Different Hemodynamic Adaptations Between Heart Failure Patients with Preserved and Reduced Ejection Fraction.
    Fu TC; Yang NI; Wang CH; Cherng WJ; Chou SL; Pan TL; Wang JS
    Am J Phys Med Rehabil; 2016 Jan; 95(1):15-27. PubMed ID: 26053189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a cardiac rehabilitation programme on plasma cardiac biomarkers in patients with chronic heart failure.
    Billebeau G; Vodovar N; Sadoune M; Launay JM; Beauvais F; Cohen-Solal A
    Eur J Prev Cardiol; 2017 Jul; 24(11):1127-1135. PubMed ID: 28452560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
    Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
    Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Cohn JN; Tognoni G;
    N Engl J Med; 2001 Dec; 345(23):1667-75. PubMed ID: 11759645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise-Based Rehabilitation for Heart Failure: Clinical Evidence.
    Ding R
    Adv Exp Med Biol; 2017; 1000():31-49. PubMed ID: 29098614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of inspiratory muscle training in patients with heart failure with preserved ejection fraction.
    Palau P; Domínguez E; Núñez E; Schmid JP; Vergara P; Ramón JM; Mascarell B; Sanchis J; Chorro FJ; Núñez J
    Eur J Prev Cardiol; 2014 Dec; 21(12):1465-73. PubMed ID: 23864363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly.
    Aronow WS
    Geriatrics; 2006 Aug; 61(8):16-20. PubMed ID: 16901193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
    Kitzman DW; Brubaker P; Morgan T; Haykowsky M; Hundley G; Kraus WE; Eggebeen J; Nicklas BJ
    JAMA; 2016 Jan; 315(1):36-46. PubMed ID: 26746456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
    From AM; Borlaug BA
    Cardiovasc Ther; 2011 Aug; 29(4):e6-21. PubMed ID: 20370792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
    Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD;
    JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.